Top compounds associated with response to IRX4


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.071 0.04
mRNA BMS-708163 GDSC1000 pan-cancer AAC 0.076 0.04
mRNA 681640 GDSC1000 pan-cancer AAC 0.082 0.04
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.097 0.04
mRNA PF-4708671 GDSC1000 pan-cancer AAC 0.076 0.05
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.068 0.05
mRNA paclitaxel gCSI pan-cancer AAC -0.12 0.05
mRNA Bosutinib GDSC1000 pan-cancer AAC 0.071 0.05
mRNA TAE684 CCLE pan-cancer AAC -0.094 0.05
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC 0.11 0.05
Download CSV